UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 301

Sortiert nach

Type I interferon in the pathogenesis of lupus

The Journal of immunology (1950), 2014-06, Vol.192 (12), p.5459-5468

Crow, Mary K

2014

Volltextzugriff (PDF)

Advances in understanding the role of type I interferons in systemic lupus erythematosus

Current opinion in rheumatology, 2014-09, Vol.26 (5), p.467-474

Crow, Mary K

2014

Volltextzugriff (PDF)

Type I Interferons in Autoimmune Disease

Annual review of pathology, 2019-01, Vol.14, p.369

2019

Volltextzugriff (PDF)

Use of Anakinra to Prevent Mechanical Ventilation in Severe COVID‐19: A Case Series

Arthritis & rheumatology (Hoboken, N.J.), 2020-12, Vol.72 (12), p.1990-1997

2020

Volltextzugriff (PDF)

Type I and II interferon signatures in Sjogren's syndrome pathogenesis: Contributions in distinct clinical phenotypes and Sjogren's related lymphomagenesis

Journal of autoimmunity, 2015-09, Vol.63, p.47-58

2015

Volltextzugriff (PDF)

Type I interferon in organ-targeted autoimmune and inflammatory diseases

Arthritis research & therapy, 2010, Vol.12 Suppl 1 (Suppl 1), p.S5-S5

Crow, Mary K

2010

Volltextzugriff (PDF)

Targeting of type I interferon in systemic autoimmune diseases

Translational research : the journal of laboratory and clinical medicine, 2015-02, Vol.165 (2), p.296-305

2015

Volltextzugriff (PDF)

Investigation of Possible Link Between Interferon-α and Lyme Disease

Emerging infectious diseases, 2023-11, Vol.29 (11), p.2409-2409

2023

Volltextzugriff (PDF)

Activation of the type I interferon pathway in primary Sjogren’s syndrome

Journal of autoimmunity, 2010-11, Vol.35 (3), p.225-231

2010

Volltextzugriff (PDF)

Imatinib mesylate (Gleevec) in the treatment of diffuse cutaneous systemic sclerosis: results of a 1-year, phase IIa, single-arm, open-label clinical trial

Annals of the rheumatic diseases, 2011-06, Vol.70 (6), p.1003-1009

2011

Volltextzugriff (PDF)

Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE

Nature Immunology, 2007-05, Vol.8 (5), p.487-496

2007

Volltextzugriff (PDF)

Synovial inflammation in patients undergoing arthroscopic meniscectomy: Molecular characterization and relationship to symptoms

Arthritis & rheumatology (Hoboken, N.J.), 2011-02, Vol.63 (2), p.391-400

2011

Volltextzugriff (PDF)

Interferon target-gene expression and epigenomic signatures in health and disease

Nature immunology, 2019-12, Vol.20 (12), p.1574

2019

Volltextzugriff (PDF)

Innate immune system activation in osteoarthritis: is osteoarthritis a chronic wound?

Current opinion in rheumatology, 2008-09, Vol.20 (5), p.565-572

2008

Volltextzugriff (PDF)

Mitochondrial DNA promotes autoimmunity

Science (American Association for the Advancement of Science), 2019-12, Vol.366 (6472), p.1445-1446

Crow, Mary K

2019

Volltextzugriff (PDF)

Advances in lupus therapeutics: Achieving sustained control of the type I interferon pathway

Current opinion in pharmacology, 2022-12, Vol.67, p.102291-102291, Article 102291

Crow, Mary K.

2022

Volltextzugriff (PDF)

Reactivity of IgG With the p40 Protein Encoded by the Long Interspersed Nuclear Element 1 Retroelement: Comment on the Article by Carter et al

Arthritis & rheumatology (Hoboken, N.J.), 2020-02, Vol.72 (2), p.374-376

Crow, Mary K.

2020

Volltextzugriff (PDF)

Diagnoses Without Names: Challenges for Medical Care, Research, and Policy

1, 2022

Volltextzugriff (PDF)

Arterial stiffness in chronic inflammatory diseases

Hypertension (Dallas, Tex. 1979), 2005-07, Vol.46 (1), p.194-199

2005

Volltextzugriff (PDF)

Interferon-alpha: A Therapeutic Target in Systemic Lupus Erythematosus

Rheumatic diseases clinics of North America, 2010-02, Vol.36 (1), p.173-186

Crow, Mary K., MD

2010

Volltextzugriff (PDF)

MTHFR gene variants and non-MALT lymphoma development in primary Sjogren's syndrome

Scientific reports, 2017-08, Vol.7 (1), p.7354-8, Article 7354

2017

Volltextzugriff (PDF)

When a Diagnosis Has No Name: Uncertainty and Opportunity

ACR open rheumatology, 2022-03, Vol.4 (3), p.197-201

2022

Volltextzugriff (PDF)

Type I interferons in host defence and inflammatory diseases

Lupus science & medicine, 2019-01, Vol.6 (1), p.e000336-e000336

2019

Volltextzugriff (PDF)

Sarcoidosis Triggered by Interferon-Beta Treatment of Multiple Sclerosis: A Case Report and Focused Literature Review

Seminars in arthritis and rheumatism, 2012-10, Vol.42 (2), p.206-212

2012

Volltextzugriff (PDF)

Microarray analysis of gene expression in lupus

Arthritis research & therapy, 2003-01, Vol.5 (6), p.279-287

2003

Volltextzugriff (PDF)

1 – 25 von 301

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(215)
Mit Volltextzugriff
(255)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(301)
Japanisch
(39)

Erscheinungsjahr

n.n

Thema

Science & Technology
(164)
Life Sciences & Biomedicine
(159)
Humans
(148)
Rheumatology
(73)
Biological And Medical Sciences
(69)
Female
(58)
Medical Sciences
(51)
Male
(48)
Immunology
(47)
Lupus Erythematosus, Systemic - Immunology
(40)
Systemic Lupus Erythematosus
(40)
Middle Aged
(39)
Adult
(38)
Animals
(29)
Lupus
(29)
Fundamental And Applied Biological Sciences. Psychology
(25)
Lupus Erythematosus, Systemic - Genetics
(25)
Aged
(21)
Diseases Of The Osteoarticular System
(20)
Autoimmunity
(18)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Type I interferon in the pathogenesis of lupus

Advances in understanding the role of type I interferons in systemic lupus erythematosus

Type I Interferons in Autoimmune Disease

Use of Anakinra to Prevent Mechanical Ventilation in Severe COVID‐19: A Case Series

Type I and II interferon signatures in Sjogren's syndrome pathogenesis: Contributions in distinct clinical phenotypes and Sjogren's related lymphomagenesis

Type I interferon in organ-targeted autoimmune and inflammatory diseases

Targeting of type I interferon in systemic autoimmune diseases

Investigation of Possible Link Between Interferon-α and Lyme Disease

Activation of the type I interferon pathway in primary Sjogren’s syndrome

Imatinib mesylate (Gleevec) in the treatment of diffuse cutaneous systemic sclerosis: results of a 1-year, phase IIa, single-arm, open-label clinical trial

Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE

Synovial inflammation in patients undergoing arthroscopic meniscectomy: Molecular characterization and relationship to symptoms

Interferon target-gene expression and epigenomic signatures in health and disease

Innate immune system activation in osteoarthritis: is osteoarthritis a chronic wound?

Mitochondrial DNA promotes autoimmunity

Advances in lupus therapeutics: Achieving sustained control of the type I interferon pathway

Reactivity of IgG With the p40 Protein Encoded by the Long Interspersed Nuclear Element 1 Retroelement: Comment on the Article by Carter et al

Diagnoses Without Names: Challenges for Medical Care, Research, and Policy

Arterial stiffness in chronic inflammatory diseases

Interferon-alpha: A Therapeutic Target in Systemic Lupus Erythematosus

MTHFR gene variants and non-MALT lymphoma development in primary Sjogren's syndrome

When a Diagnosis Has No Name: Uncertainty and Opportunity

Type I interferons in host defence and inflammatory diseases

Sarcoidosis Triggered by Interferon-Beta Treatment of Multiple Sclerosis: A Case Report and Focused Literature Review

Microarray analysis of gene expression in lupus

Suchergebnisse filtern